Skin Cancer
-
Sea Squirt Compound Shows Promise Against Melanoma Cells
NEW YORK, July 8 — 1%. That figure that matters: melanoma accounts for about 1% of all skin cancers, yet it causes…
-
NHS urges Britons to check moles for ABCDE melanoma signs this summer
Britons with moles are being told to look for five specific changes this summer. The NHS posted a checklist on social media…
-
QIMR Berghofer study: 70% of Queenslanders used skin cancer services in eight years
For decades, Queensland has been the place where the sun doesn’t just shine — it attacks. The state holds the world’s highest…
-
Tiny Antarctic creature may hold key to melanoma treatment
TAMPA, June 29 — The bottom line: a toxin from a tiny sea creature collected off Antarctica has already killed melanoma cells…
-
Antarctic sea creature toxin shows melanoma-killing potential in mouse study
A toxin harvested from a tiny sea creature collected off Antarctica has killed melanoma in mice without harming the mice. That fact…
-
Most people underapply sunscreen; here’s the correct amount
NEW YORK, June 23 — On the ground, residents describe a concerning trend when it comes to sun protection: the majority of…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992